Regulatory Post-Marketing Surveillance (PMS) Study for ADACEL (Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined Vaccine for Adult).

Trial Profile

Regulatory Post-Marketing Surveillance (PMS) Study for ADACEL (Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined Vaccine for Adult).

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jan 2017

At a glance

  • Drugs DTaP vaccine (Primary)
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Adverse reactions
  • Sponsors Sanofi; sanofi pasteur
  • Most Recent Events

    • 24 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
    • 11 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top